(47 days)
Not Found
994283, 994282
No
The summary explicitly states that analysis is performed using "standard algorithms and user input" and does not mention AI, ML, or related terms.
No
The device is a software for analyzing medical images and provides data to support clinical decision-making, but it explicitly states it is "not intended to be a source of medical advice or to determine or recommend a course of action or treatment for a patient." Therapeutic devices are used for treatment or diagnosis, and this device is solely for analysis and support.
Yes
The description states that Segment "provides clinically relevant and reproducible data for supporting the evaluation of the function of the chambers of the heart" and "provides quantitative data on blood flow and velocity". This data is intended "to support qualified cardiologist, radiologist or other licensed professional healthcare practitioners for clinical decision making." This aligns with the definition of a diagnostic device, which provides information used to identify a disease or condition.
Yes
The device description explicitly states that Segment is a software for analysis of cardiovascular MR images and does not mention any associated hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Device function: Segment analyzes images acquired from an MR scanner. It does not analyze biological specimens.
- Intended Use: The intended use clearly states it analyzes "DICOM-compliant cardiovascular images acquired from magnetic resonance (MR) scanners."
Therefore, Segment falls under the category of medical imaging analysis software, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Segment is a software that analyzes DICOM-compliant cardiovascular images acquired from magnetic resonance (MR) scanners. Segment specifically analyzes the function of the heart and its major vessels using multi-slice, multi-frame and velocity encoded MR images. It provides clinically relevant and reproducible data for supporting the evaluation of the function of the chambers of the heart such as left and right ventricular volumes, ejection fractions, stroke volumes, peak ejection and filling rates, myocardial mass, regional wall thickness, fractional thickening and wall motion. It also provides quantitative data on blood flow and velocity in the arterial vessels and at the heart valves. Segment is tested on MR images acquired from both 1.5 T and 3 T MR scanners. The data produced by Segment is intended to be used to support qualified cardiologist, radiologist or other licensed professional healthcare practitioners for clinical decision making. It is a support tool that provides relevant clinical data as a resource to the clinician and is not intended to be a source of medical advice or to determine or recommend a course of action or treatment for a patient.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
Segment is a software for analysis of cardiovascular MR images. Segment provides clinical quantitative data by analyzing multi-slice, multi-phase DICOM compatible cardiovascular MR images. Functional and blood flow analysis is performed using 2D, 3D and 4D data sets using standard algorithms and user input. MR images may be imported from various sources including images stored on portable media, network storage devices, PACS, and other vendor systems and supports cardiovascular MR images from all of the major MRI scanner vendors. Segment can be used for quantitative and qualitative analysis of cardiovascular MR images.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Magnetic Resonance (MR)
Anatomical Site
Heart and its major vessels
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Qualified cardiologist, radiologist or other licensed professional healthcare practitioners / Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Extensive testing of the software package is performed by programmers, by non-programmers, quality assurance staff and by potential customers prior to commercial release (see Section 16.9). Conclusion: the subject device, Segment is as safe and effective as the predicate device and posses no new questions of safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
MRI-MASS (510(k) 994283), MRI-FLOW (510(k) 994282)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Section 5
MAY 12 2009
510(k) Summary
510 (k) Summary 5
Submitter:
Medviso AB Thulehemsvägen 157 SE-224 67 Lund, Sweden +46-76-1836442
Date Prepared: May 11, 2009
Contact Person(s): Einar Heiberg, President +46-76-1836442 einar@medviso.com
Device Trade Name: Segment (Segment)
Device Common Name: Cardiovascular image analysis software
Classification Name: Class II - System, Image Processing
Product Code / Regulation Number: LLZ / 892.2050
Substantially Equivalent To:
MRI-MASS and MRI-FLOW Medis Medical Imaging Systems BV Schuttersveld 9 2316 XG Leiden The Netherlands
Device Description:
Segment is a software for analysis of cardiovascular MR images. Segment provides clinical quantitative data by analyzing multi-slice, multi-phase DICOM compatible cardiovascular MR images. Functional and blood flow analysis is performed using 2D, 3D and 4D data sets using standard algorithms and user input. MR images may be imported from various sources including images stored on portable media, network storage devices, PACS, and other vendor systems and supports cardiovascular MR images from all of the major MRI scanner vendors. Segment can be used for quantitative and qualitative analysis of cardiovascular MR images.
MEDVISO AB Thulehemsvägen 157 SE-224 67 Lund, Sweden tel: +46-76-1836442 www.medviso.com
MEDVISO
Page 5-1 Segment FDA 510(k) Submission
1
Section 5
KC90833
Page 2 of 4
510(k) Summary
Intended Use:
Segment is a software that analyzes DICOM-compliant cardiovascular images acquired from magnetic resonance (MR) scanners. Segment specifically analyzes the function of the heart and its major vessels using multi-slice, multi-frame and velocity encoded MR images. It provides clinically relevant and reproducible data for supporting the evaluation of the function of the chambers of the heart such as left and right ventricular volumes, ejection fractions, stroke volumes, peak ejection and filing rates, myocardial mass, reqional wall thickness, fractional thickening and wall motion. It also provides quantitative data on blood flow and velocity in the arterial vessels and at the heart valves. Segment is tested on MR images acquired from both 1.5 T and 3 T MR scanners. The data produced by Segment is intended to be used to support qualified cardiologist, radiologist or other licensed professional healthcare practitioners for clinical decision making. It is a support tool that provides relevant clinical data as a resource to the clinician and is not intended to be a source of medical advice or to determine or recommend a course of action or treatment for a patient.
Technological Comparison to Predicate Device:
The proposed and predicate devices are both devices that can be used for the analysis of multi-slice, multi-frame and phase encoded DICOM-compliant MR image data sets. Both complete their analysis of these data sets using standard algorithms and user inputs to delineate the myocardial and arterial vascular wall from surrounding tissue and blood (wall contours.) Both render wall contours either fully automatically, semi-automatically, manually or in combination providing clinically relevant data. Both devices allow user input to recalculate rendered numeric output based on a qualified user's expertise. The proposed and predicate device can be operated from a personal computer. Segment has substantially equivalent features and specifications to the predicate device.
Laboratory and Clinical Testing:
Segment is a software intended for analyzing DICOM-compliant cardiovascular images acquired from MRI scanners. Segment does not in any way alter the images. Images from MRI scanners have been proven and accepted clinically.
Segment is used for image analysis and quantification of cardiovascular images providing clinically relevant numeric computations that support a cardiologist or radiologist in their diagnosis of heart disease. Segment contains no image digitizers and uses only lossless compression. On this basis, Medviso AB believes that clinical investigation is not necessary.
MEDVISO AB Thulehemsvägen 157 SE-224 67 Lund, Sweden tel: +46-76-1836442 www.medviso.com
MEDVISO
Page 5-2 Segment FDA 510(k) Submission
2
Section 5
K090833
Page 3 of 4
510(k) Summary
Extensive testing of the software package is performed by programmers, by non-programmers, quality assurance staff and by potential customers prior to commercial release (see Section 16.9). We conclude that the subject device, Segment is as safe and effective as the predicate device and posses no new questions of safety and effectiveness.
Adverse Affects on Health:
The potential hazards are identified in the Hazard Analysis (section 16.3) and are controlled by:
- · Designing controls directed at the cause and/or
- Introducing protective measures and/or
- · Warning the Users
All identified hazards are mitigated to minor levels of concern.
Summary of Safety and Effectiveness:
The intended use of Segment is for analyzing selected DICOM-compliant cardiovascular MRI. It is a support tool that provides relevant data for the clinician that is evaluating a patient's cardiovascular system using functional data such as ejection fraction, stoke volumes and cardiac output. The image analysis provided by Segment makes the images more clinically useful for the physician in making his diagnosis. Segment does not in any way alter the MRI imaging data in the analytical process. Segment provides assistance to a professionally trained physician and all of the information is subject to his/her oversight and control. Any potential hazard and for reduction in effectiveness that may be due to the failure of the hardware or software components of Seament will be mitigated by the user of the device.
Segment runs on standard PC hardware and Microsoft Windows XP or Microsoft Windows Vista operating system software. The use of these industry standard components provide for maximum availability and reliability making Segment more effective for its intended use. The predicate device also uses standard PC hardware and another industry standard operating system, UNIX. The current versions of these industry standard products used for the operation Segment are of greater effectiveness and any safety concerns caused by failure of the off-the-shelf components and the Segment software component are no greater than the predicate device.
See Substantial Equivalence Chart in Section 12 and copies of the 510(k) Premarket Notification summaries for the predicate devices in Appendices F and G for comparison to the intended use Segment and discussions of hazard and safety concerns.
MEDVISO AB Thulehemsvägen 157 SE-224 67 Lund, Sweden tel: +46-76-1836442 www.medviso.com
MEDVISO
Page 5-3 Segment FDA 510(k) Submission
3
Image /page/3/Picture/0 description: The image shows handwritten text on a white background. The text includes "K090833" on the top line, followed by "Page 4 of 4" on the second line. The bottom line reads "510(k) Sum".
Conclusions:
We conclude that the subject device Segment is as safe and effective as the predicate device and poses no new questions of safety and effectiveness. Segment performs in accordance with its intended use as well as the Medis MRI-MASS and MRI-FLOW cardiovascular MRI image analysis products currently on the market. Medviso AB considers the features of the Segment to be substantially equivalent to the subset of features in common with the MRI-MASS (510(k) 994283) and MRI-FLOW (510(k) 994282)
MEDVISO AB Thulehemsvägen 157 SE-224 67 Lund, Sweden tel: +46-76-1836442 www.medviso.com
MEDVISO
Page 5-4 Segment FDA 510(k) Submission
4
Image /page/4/Picture/0 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular, with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is an abstract symbol that resembles an eagle or bird in flight. The symbol is composed of three curved lines that form the body and wings of the bird.
DEPARTMENT OF HEALTH & HUMAN SERVICES
MAY 12 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Einar Heiberg President, CEO Medviso Thulehemsvagen 157 Lund SE-224 67 SWEDEN
Re: K090833
Trade/Device Name: Segment / Image Processing System Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system
Regulatory Class: II Product Code: LLZ Dated: March 18, 2009 Received: March 26, 2009
Dear Mr. Heiberg:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050,
5
Page 2
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.
21 CFR 876.xxx 21 CFR: 884.xxx 21 CFR 892.xxx Other
(Gastroenterology/Renal/Urology) (Obstetrics/Gynecology) (Radiology)
(240) 276-0115 (240) 276-0115 (240) 276-0120 (240) 276-0100
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please contact the CDRH/Office of Surveillance and Biometrics/Division of Postmarket Surveillance at 240-276-3464. For more information regarding the reporting of adverse events, please go to http://www.fda.gov/cdrh/mdr/.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
:
6
Indications for Use 4
Indications for Use Statement
K090833 510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________
Device Name: Segment / Image Processing System
Indications For Use:
Segment is a software that analyzes DICOM-compliant cardiovascular images acquired from magnetic resonance (MR) scanners. Segment specifically analyzes the function of the heart and its major vessels using multi-slice, multi-frame and velocity encoded MR images. It provides clinically relevant and reproducible data for supporting the evaluation of the function of the chambers of the heart such as left and right ventricular volumes, ejection fractions, stroke volumes, peak ejection and filling rates, myocardial mass, regional wall thickness, fractional thickening and wall motion. It also provides quantitative data on blood flow and velocity in the arterial vessels and at the heart valves. Segment is tested on MR images acquired from both 1.5 T and 3 T MR scanners. The data produced by Segment is intended to be used to support qualified cardiologist, radiologist or other licensed professional healthcare practitioners for clinical decision making. It is a support tool that provides relevant clinical data as a resource to the clinician and is not intended to be a source of medical advice or to determine or recommend a course of action or treatment for a patient.
Prescription Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) |
|---|
| Page 1 of 1 |
| MEDVISO AB | Page 4-1 | |
|---|---|---|
| Thulehemsv\u00e4gen 157 | (Division Sign-Off) | Segment |
| SE-224 67 Lund, Sweden | FDA 510(k) Submission | |
| tel: +46-76-1836442 | Division of Reproductive, Abdominal and | |
| www.medviso.com | Radiological Devices | 2009-05-11 |
| 510(k) Number | K090833 |